🇺🇸 CARBIDOPA; LEODOPA in United States

CARBIDOPA; LEODOPA (LEODOPA) regulatory status in United States.

Marketing authorisations

FDA

  • Status: approved

FDA

  • Application: ANDA210911
  • Marketing authorisation holder: ZYDUS PHARMS USA INC
  • Local brand name: CARBIDOPA; LEODOPA
  • Indication: CAPSULE, EXTENDED RELEASE
  • Status: approved

Read official source →

CARBIDOPA; LEODOPA in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is CARBIDOPA; LEODOPA approved in United States?

Yes. FDA has authorised it; FDA has authorised it.

Who is the marketing authorisation holder for CARBIDOPA; LEODOPA in United States?

ZYDUS PHARMS USA INC is the originator. The local marketing authorisation holder may differ — check the official source linked above.